.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Fish and Richardson
McKinsey
Colorcon
Moodys
Queensland Health
Argus Health
Merck
Covington

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,324,283

« Back to Dashboard

Which drugs does patent 8,324,283 protect, and when does it expire?


Patent 8,324,283 protects GILENYA and is included in one NDA. There has been one Paragraph IV challenge on Gilenya.

This patent has ninety-two patent family members in forty-two countries.

Summary for Patent: 8,324,283

Title:Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) a sugar alcohol.
Inventor(s): Oomura; Tomoyuki (Oita, JP), Pudipeddi; Madhusudhan (Edison, NJ), Ruegger; Colleen (Morris Plains, NJ), Royce; Alan E (Saylorsburg, PA), Sasaki; Masaki (Oita, JP), Tamura; Tokuhiro (Fukuoka, JP)
Assignee: Novartis AG (Basel, CH) Mitsubishi Pharma Corporation (Osaka, JP)
Application Number:12/189,323
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
NovartisGILENYAfingolimodCAPSULE;ORAL022527-001Sep 21, 2010RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,324,283

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation2005134173► Subscribe
Portugal1613288► Subscribe
Poland2316431► Subscribe
Peru13522013► Subscribe
Peru07432009► Subscribe
Peru06762015► Subscribe
Peru03962005► Subscribe
Peru02002013► Subscribe
New Zealand592339► Subscribe
New Zealand586280► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Covington
Cantor Fitzgerald
Medtronic
US Army
Farmers Insurance
McKinsey
Queensland Health
Novartis
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot